Activated partial thromboplastin time is a predictive parameter for further miscarriages in cases of recurrent fetal loss

Fertility and Sterility

Volumn 70, Issue 6, 1998, Pages 1081-1084

  Ogasawara, Mayumi ^a   Aoki, Koji ^a   Katano, Kinue ^a   Aoyama, Tomomi ^a   Ozaki, Yasuhiko ^a   Suzumori, Kaoru ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Activated partial thromboplastin time; Antiphospholipid antibody; Fibrinogen; Prothrombin time; Recurrent miscarriage

Indexed keywords

FIBRINOGEN; PHOSPHOLIPID ANTIBODY; PROTHROMBIN; THROMBOPLASTIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PREDICTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RECURRENT ABORTION; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ANTIBODIES, ANTIPHOSPHOLIPID; FEMALE; FIBRINOGEN; HUMANS; KARYOTYPING; PARTIAL THROMBOPLASTIN TIME; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; PROTHROMBIN TIME;

EID: 0032401013     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00336-7     Document Type: Article

References (21)

1. Warburton D., Kline J., Stein Z., Hutzler M., Chin A., Hassold T. Does the karyotype of a spontaneous abortion predict the karyotype of a subsequent abortion? Evidence from 273 women with two karyotyped spontaneous abortions. Am J Hum Genet. 41:1987;465-473.
2. Cowchock F.S., Gibas Z., Jackson L.G. Chromosome errors as a cause of spontaneous abortion the relative importance of maternal age and obstetric history . Fertil Steril. 59:1993;1011-1014.
3. Aoki K., Kajiura S., Matsumoto Y., Ogasawara M., Yagami Y., Gleicher N. Elevated natural killer cell activity at preconception as a predictor of a subsequent miscarriage a prospective cohort study . Lancet. 345:1995;1342-1344.
4. Ogasawara M., Kajiura S., Katano K., Aoyama T., Aoki K. Are serum progesterone levels predictive of recurrent miscarriage in future pregnancies? Fertil Steril. 68:1997;806-809.
5. Ogasawara M., Aoki K., Kajiura S., Yagami Y. Are antinuclear antibodies predictive of recurrent miscarriage? Lancet. 347:1996;1183-1184.
6. Brenner B., Shapira A., Bahari C., Haimovich L., Seligsohn U. Hereditary protein C deficiency during pregnancy. Am J Obstet Gynecol. 157:1987;1160-1161.
7. Tharakan T., Baxi L.V., Diuguid D. Protein S deficiency in pregnancy a case report . Am J Obstet Gynecol. 168:1993;141-142.
8. Rotmensch S., Liberati M., Mittelmann M., Rafael Z.B.R. Activated protein C resistance and adverse pregnancy outcome. Am J Obstet Gynecol. 177:1997;170-173.
9. Rai R.S., Regan L., Chitolie A., Donald J.G., Cohen H. Placental thrombosis and second trimester miscarriage in association with activated protein C resistance. Br J Obstet Gynaecol. 103:1996;842-844.
10. Preston F.E., Rosendaal F.R., Walker I.D., Briet E., Berntorp E., Conard J., et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 348:1996;913-916.
11. Farquharson R.G., Pearson J.F., John L. Lupus anticoagulant and pregnancy management. Lancet. 28:1984;228-229.
12. Gharavi A.E., Harris E.N., Asherson R.A., Hughes G.R. Anticardiolipin antibodies isotype distribution and phospholipid specificity . Ann Rheum Dis. 46:1987;1-6.
13. Hayashi Y., Aoki K., Kunimatsu M., Sasaki M., Yagami Y. A sensitive assay for antiphosphatidylethanolamine antibody in patients with recurrent fetal loss. Acta Obstet Gynecol Jpn. 42:1990;1565-1570.
14. Matsuura E., Igarashi Y., Yasuda T., Triplett D.A., Koike T. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med. 179:1994;457-462.
15. Ogasawara M., Aoki K., Matsuura E., Sasa H., Yagami Y. Antiβ2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss prevalence and clinical association . Lupus. 5:1996;587-592.
16. Gris J.C., Neveu S.R., Maugard C., Tailland M.L., Brun S., Courtieu C., et al. Prospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. Thromb Haemost. 77:1997;1096-1103.
17. Graeff H., Ernst E., Bocaz J.A., von Hugo R., Hafter R. Evaluation of hypercoagulability in septic abortion. Haemostasis. 5:1976;285-294.
18. Catanzarite V.A., Novotny W.F., Cousins L.M., Schneider J.M. Pregnancies in a patient with congenital absence of prothrombin activity case report . Am J Perinatol. 14:1997;135-138.
19. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship is successful pregnancy a Th2 phenomenon? Immunol Today. 14:1993;353-356.
20. Tangri S., Raghupathy R. Expression of cytokines in placentas of mice undergoing immunologically mediated spontaneous fetal resorptions. Biol Reprod. 49:1993;850-856.
21. Aoki K., Kajiura S., Matsumoto Y., Yagami Y. Clinical evaluation of immunotherapy in early pregnancy with X-irradiated paternal mononuclear cells for primary recurrent aborters. Am J Obstet Gynecol. 169:1993;649-653.